Widowers are more likely to be diagnosed with advanced #ProstateCancer medicalxpress.com/news/2021-08-w…

Effects of #exercise on cardiorespiratory fitness and biochemical progression in men with localized #ProstateCancer under #ActiveSurveillance. jamanetwork.com/journals/jamao…

You are invited to the webinar where brad walsh shares the story of MiCheck® development and the current activities in rolling the test out in Australia, the US and China. Register to participate in the event or to get a recording: bit.ly/3zuKF04 HBS Alumni

This study provides insight into how men with #metastatic #ProstateCancer should be counselled regarding future health risks renalandurologynews.com/home/news/urol…

Bone-protecting agents reduce fracture risk during #ProstateCancer treatment oncnursingnews.com/view/bone-prot…

These findings highlight the importance of considering mental wellbeing during follow-up for early recognition and treatment of #ProstateCancer sciencedirect.com/science/articl…

Minomic is thrilled to cooperate with the #CLIAx team that allows us to tap into the expertise in laboratory testing. It is a ‘soft landing’ site to enter the U.S. market for MiCheck Prostate test rollout. minomic.com/micheck-prosta…

#Plantbased diets are associated with a decreased risk of #erectile dysfunction, lower #PSA rates, and possibly a lower rate of total and fatal #ProstateCancer among younger men. medpagetoday.com/meetingcoverag…

We are pleased to welcome @DrSiddireddy who has joined us as the key postdoctoral researcher overseeing our MiCheck® clinical studies at Macquarie University Hospital. She is the recipient of STEM+ Business Fellowship from CSIRO in partnership with Minomic and Macquarie Medical School

According to Dr Stacy Loeb, MD, younger men who consume healthy #plantbased foods, dramatically lower their risk of developing advanced #ProstateCancer healio.com/news/primary-c…

Investigators found the highest prostate cancer death rates among patients with a primary Gleason 5 pattern. renalandurologynews.com/home/news/urol…

Minomic is pleased to be part of the Australian Government vision to build sovereign capability. Read more: minomic.com/federal-govern… #ProstateCancer #Investment #MedTech

View the presentation of CEO Brad Walsh brad walsh on MiCheck® Prostate in the video linkedin.com/feed/update/ur… #ProstateCancer

Unprecedented improvements in the survival of men with #Advanced #ProstateCancer thanks to the access to therapies approved over the last decade medicalxpress.com/news/2022-05-p…

Implementing risk-stratified screening, such as biomarkers, minimizes overdiagnosis and avoids #biopsy in men with low-risk prostate cancer while addressing the rising trends of high-grade and #metastatic #ProstateCancer. news.weill.cornell.edu/news/2022/04/l…

#prostatecancer #detection #USANZ22

The number of men being diagnosed with #ProstateCancer is expected to increase by as much as 43% between now and 2040. Early and accurate diagnosis is key to boosting survival rates. MiCheck® Prostate is designed to better-detect aggressive prostate cancer.

We had the opportunity to share Minomic’s journey from genesis of the company to launch of MiCheck® Prostate in the US market with 360Dx, a leading media outlet for the #diagnostics industry. Subscribe to 360Dx to read the full article: 360dx.com/cancer/austral…

MiCheck Prostate, a non-invasive prostate cancer test developed in Australia as part of a collaborative project between Minomic Int'l & @AMGC_Ltd has been successfully commercialised. #project #manufacturing #australia #medical #prostatecancer manmonthly.com.au/minomic-launch…

Come and hear from our CEO brad walsh why MiCheck® Prostate is such a great tool in the #prostatecancer journey. Minomic's presentation will take place at 4pm at 8 Hadenfeld Rd, Macquarie Park. Free tickets are here: events.humanitix.com/mqi-demo-day-2… #deeptech